Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA

Title
Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA
Authors
Keywords
-
Journal
ESMO Open
Volume 6, Issue 1, Pages 100041
Publisher
Elsevier BV
Online
2021-01-19
DOI
10.1016/j.esmoop.2020.100041

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now